1月30日,包括荣昌生物、科兴制药、君实生物、百利天恒、复旦张江等多家创新药企业发布2025年业绩预告,那么2025年这些药企战绩如何?其中,荣昌生物预计2025全年实现营业收入约32.5亿元,较上年同期增加15.33亿元,同比增幅约89%;预计实现净利润约7.16亿元,同比实现扭亏为盈;扣非净利润约7850万元,同样实现扭亏为盈。对于2025年业绩的突破,荣昌生物表示,核心驱动力来自主营业务增长...
Source Link1月30日,包括荣昌生物、科兴制药、君实生物、百利天恒、复旦张江等多家创新药企业发布2025年业绩预告,那么2025年这些药企战绩如何?其中,荣昌生物预计2025全年实现营业收入约32.5亿元,较上年同期增加15.33亿元,同比增幅约89%;预计实现净利润约7.16亿元,同比实现扭亏为盈;扣非净利润约7850万元,同样实现扭亏为盈。对于2025年业绩的突破,荣昌生物表示,核心驱动力来自主营业务增长...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.